- Home
- PFIS vs VNDA Comparison
PFIS vs VNDA Comparison
Compare PFIS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFIS | VNDA |
|---|---|---|
| Founded | 1905 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.3M | 425.5M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | PFIS | VNDA |
|---|---|---|
| Price | $48.10 | $8.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $13.13 |
| AVG Volume (30 Days) | 26.2K | ★ 2.8M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | ★ 582.67 | N/A |
| EPS | ★ 5.29 | N/A |
| Revenue | $182,622,000.00 | ★ $212,074,000.00 |
| Revenue This Year | $68.41 | $12.01 |
| Revenue Next Year | $4.87 | $21.57 |
| P/E Ratio | $9.10 | ★ N/A |
| Revenue Growth | ★ 89.84 | 11.12 |
| 52 Week Low | $38.90 | $3.81 |
| 52 Week High | $54.20 | $9.60 |
Technical Indicators
Market Signals| Indicator | PFIS | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 68.93 |
| Support Level | $49.00 | $6.87 |
| Resistance Level | $49.97 | $9.60 |
| Average True Range (ATR) | 1.27 | 0.49 |
| MACD | -0.50 | 0.13 |
| Stochastic Oscillator | 1.47 | 60.87 |
Price Performance
Historical ComparisonAbout PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.